[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Cabaletta Bio Inc (CABA)

Cabaletta Bio Inc (CABA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cabaletta Bio Inc 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 USA

www.cabalettabio.com Employees: 156 P: 267-759-3100

Sector:

Medical

Description:

Cabaletta Bio Inc. is a clinical stage biotechnology company. It is focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's product pipeline consists of DSG3-CAART, DSG3/1-CAART, MuSK-CAART and FVIII-CAART which are in clinical stage. Cabaletta Bio Inc. is based in Philadelphia, United States.

Key Statistics

Overview:

Market Capitalization, $K 559,498
Enterprise Value, $K 476,518
Shares Outstanding, K 169,545
Float, K 158,626
% Float 93.56%
Short Interest, K 42,796
Short Float 25.24%
Days to Cover 12.41
Short Volume Ratio 0.53
% of Insider Shareholders 6.44%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -167,860 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -51,020 K
EBIT, $ -185,520 K
EBITDA, $ -173,200 K

Growth:

1-Year Return 127.59%
3-Year Return -76.19%
5-Year Return -71.55%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -45.83%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 08/13/26
Next Earnings Date 11/09/26
Earnings Per Share ttm -1.57
EPS Growth vs. Prev Qtr 12.82%
EPS Growth vs. Prev Year 53.42%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CABA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -128.27%
Return-on-Assets % -95.47%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.42
Book Value/Share 1.29
Interest Coverage -82.93
60-Month Beta 3.27
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.